News
Aphena to Exhibit at GPhA Annual Meeting Business Exposition
February 2015
COOKEVILLE — Eric Allen and Paul Glintenkamp of Aphena Pharma Solutions will be exhibiting at the Generic Pharmaceutical Association (GPhA) Annual Business Expo, set for Feb. 9-11 at the Fontainebleau Miami Beach in Miami Beach, Florida. We'll be meeting with our customers and prospective new clients to learn about their business models and their packaging and manufacturing needs, as well as to discuss strategies for development and implementation for serialization....
MoreAphena Adds Convenience Vial Packaging Line
January 2015
Aphena is proud to announce the addition of a new convenience vial packaging line located in our Whippany, N.J., facility. The fully automated line is capable of packaging a wide range of capsules and tablets, both in a 16mm and a 22mm vial, as well as labeling the vials and packaging them into unit-of-sale cartons....
MoreAphena Adds Fourth Bottle Line to New Jersey Facility
December 2014
TREVOSE, Pa., Dec. 2, 2014 — Aphena Pharma Solutions recently installed a new bottling line in our Whippany, New Jersey, facility to add to our offerings for contract packaging. Aphena now has four bottle lines in our New Jersey site to complement the six bottle lines we have in our Cookeville, Tennessee, location....
MoreAphena to Display at Global Conference on Barrier Packaging
October 2014
Aphena Pharma is excited to participate in this year's Barrier Pharma Packaging 2014, an international conference on polymers hosted by Applied Market Information, LLC. The conference will take place October 14-15 at the Hyatt Regency Princeton Hotel in Princeton, N.J....
MoreAphena Maryland Completes New Blending Area
October 2014
Aphena Pharma Solutions has recently added a new blending area to our Easton, Maryland, facility, giving us the ability to offer our clients heat or cold blending for large volumes of ointments, suspensions, creams, lotions, gels and other products that require heating and/or cooling....
MoreAphena's DEA Class II packaging and storage capabilities provide value with new FDA/DEA regulations
September 2014
As many in the pharmaceutical industry are aware, recent revisions to DEA regulations effective October 6, 2014, require reclassification of hydrocodone products from Class III to Class II....
MoreAphena to Help with DEA Class II Needs and More at Contract Pharma Conference
September 2014
Aphena Pharma Solutions is looking forward to seeing you and discussing your pharmaceutical, med device and OTC contracting needs this Thursday, September 18, 2014, at the Contract Pharma Conference, booth #10, in the Hyatt Regency Hotel in New Brunswick, N.J....
MoreAphena Obtains $10 Million in Financing from NewStar
March 2014
Aphena Pharma Solutions and subsidiaries ("Aphena") announced today that it has obtained a revolving credit facility totaling $10,000,000 from NewStar Business Credit, a wholly-owned subsidiary of NewStar Financial, Inc. (NASDAQ: NEWS). The revolving credit facility will be used by Aphena to refinance existing debt and support future growth....
More